Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 +0.39%81 OCF Yield % is 21.24 as of Jul. 17, 2026, which is 108% above its 10-year median of 10.21. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 852 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 96.36% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for BenQ Medical Technology's OCF Yield % or its related term are showing as below:
ROCO:4116'
s OCF Yield % Range Over the Past 10 Years
Min: 1.88 Med: 10.21 Max: 21.56
Current: 21.24
During the past 13 years, the highest OCF Yield % of BenQ Medical Technology was 21.56%. The lowest was 1.88%. And the median was 10.21%.
ROCO:4116's OCF Yield % is ranked better than 96.36% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.73
vs ROCO:4116: 21.24
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
BenQ Medical Technology OCF Yield % Related Terms
BenQ Medical Technology OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's OCF Yield % distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a OCF Yield % of 21.24 as of Jul. 17, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BenQ Medical Technology and its competitors. This is 108% above median its historical median of 10.21. Over the past decade, BenQ Medical Technology's OCF Yield % has ranged from 1.88 to 21.56. According to the industry distribution chart, BenQ Medical Technology ranks #31 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 3.6%.
Is BenQ Medical Technology's OCF Yield % too high?
BenQ Medical Technology's current OCF Yield % of 21.24 is 108% above median its 10-year median of 10.21. Over the past 10 years, this metric has ranged from a low of 1.88 to a high of 21.56. The Medical Devices & Instruments industry median OCF Yield % is 1.73. BenQ Medical Technology's value of 21.24 is 1127.7% above this industry median. Based on the distribution chart, BenQ Medical Technology ranks #31 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #31 out of 852 companies for OCF Yield %. This places BenQ Medical Technology in the top 4% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.73. BenQ Medical Technology's value of 21.24 is 1127.7% above this benchmark. Historically, BenQ Medical Technology's own OCF Yield % has ranged from 1.88 to 21.56 over the past decade. While the company's 10-year median is 10.21 vs. the industry median of 1.73, BenQ Medical Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.73, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current OCF Yield % of 21.24 is 1127.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current OCF Yield % is 21.24, which is 108% above median its own 10-year median of 10.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.60 — trading 38.1% below its estimated fair value. The current OCF Yield % is 21.24, which is 108% above median its 10-year median of 10.21 and 1127.7% above the Medical Devices & Instruments industry median of 1.73. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current OCF Yield % is 21.24 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
OCF Yield %: 21.24 (108% above median its 10-year median of 10.21)
GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
Industry Position: 1127.7% above the Medical Devices & Instruments median (#31 of 852)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
